Nicolas Cherbuin

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


4 publications

2024 | 2023 | 2022 | 2021 |
2024
 
How much do <sup>68</sup>Ga-, <sup>177</sup>Lu- and <sup>131</sup>I-based radiopharmaceuticals contribute to the global radiation exposure of nuclear medicine staff?
Struelens L., Aalbersberg E., Beels L., Cherbuin N., D'Asseler Y., De Monte F., Lopez Medina A., Del Carmen Riveira Martin M., Schoonjans W., Terwinghe C. et al., 2024/11/14. EJNMMI physics, 11 (1) p. 95. Peer-reviewed.
[DOI][Pmid][serval:BIB_876AB8BD2F1F]
2023
Finger doses due to 68Ga-labelled pharmaceuticals in PET departments, results of a multi-centre pilot study.
McCann A., Cherbuin N., Covens P., Dabin J., Haruz-Waschitz S., Gallo L., Datz H., Wierts R., Wrzesien M., Zorz A. et al., 2023/02/01. Journal of radiological protection, 43 (1). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_617D974B29C0]
2022
 
Understanding the FLASH effect to unravel the potential of ultra-high dose rate irradiation.
Kacem H., Almeida A., Cherbuin N., Vozenin M.C., 2022. International journal of radiation biology, 98 (3) pp. 506-516. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DC23578CAFF2]
2021
Commissioning of an ultra-high dose rate pulsed electron beam medical LINAC for FLASH RT preclinical animal experiments and future clinical human protocols.
Moeckli R., Gonçalves Jorge P., Grilj V., Oesterle R., Cherbuin N., Bourhis J., Vozenin M.C., Germond J.F., Bochud F., Bailat C., 2021/06. Medical physics, 48 (6) pp. 3134-3142. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_04A0655121E7]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University